AKBA Akebia Therapeutics, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · akebia.com

0.8734USD-0.58%Mkt Cap: 242.02M $P/E: —1d ago

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo (vadadustat), an oral hypo…

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited

$58.68BUSD

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB (publ)

$14.43BUSDP/E 112.9

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporated

$11.17BUSD

RDY

Dr. Reddy's Laboratories Limited

Hims & Hers Health, Inc.

$6.89BUSD

AMRX

Amneal Pharmaceuticals, Inc.

$6.84BUSDP/E 40.1

Key Statistics

Company

Market Cap242.02M USD

Enterprise Value287.08M USD

Revenue (TTM)219.06M USD

Gross Profit196.73M USD

Net Income (TTM)-5.34M USD

Revenue/Share0.82 USD

Last Price0.8734 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees194

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-2.44

PEG—

EV/EBITDA-66.82

EV/Revenue1.31

P/S1.11

P/B9.55

EPS (TTM)-0.12

EPS (Forward)-0.36

52W Range

0.81472% of range3.200

52W High3.200 USD

52W Low0.8147 USD

Profitability

Gross Margin83.29%

Oper. Margin-5.46%

EBITDA Margin-1.96%

Profit Margin-2.26%

ROE-16.39%

ROA-1.42%

Growth

Revenue Growth-21.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF67.99M USD

CapEx (TTM)8.10M USD

FCF Margin15.35%

FCF Yield13.90%

Net Debt43.64M USD

Net Debt/EBITDA-10.16

Balance Sheet

Debt/Equity1.59

Current Ratio1.43

Quick Ratio1.30

Book Value/Sh0.09 USD

Cash/Share0.56 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)3.917 USD

Upside (mean)+348.4%

Target Range1.000 USD – 6.000 USD

1.000+348.4% to mean6.000

# Analysts6

Ownership

Shares Out.277.11M

Float272.25M

Insiders1.98%

Institutions40.77%

Short Interest

Short Ratio2.4d

Short % Float7.51%

Short % Out.7.40%

Shares Short20.50M

Short (prev mo.)21.37M

Technical

SMA 500.9783 (-10.7%)

SMA 2001.228 (-28.9%)

Beta0.18

S&P 52W Chg16.45%

Avg Vol (30d)7.27M

Avg Vol (10d)5.54M

Technical Indicators

RSI (14)41.7

MACD-0.0321

MACD Signal-0.0336

MACD Hist.+0.0015

BB Upper1.005 USD

BB Middle0.9214 USD

BB Lower0.8380 USD

BB Width18.10%

ATR (14)0.0537 USD

Vol Ratio (20d)1.48x